PPARG and disease of the tendon: We identified a Runx2 inhibitor, AGA, which blocks the osteogenic differentiation of TDSCs from chemically induced tendinopathy, and a PPARγ antagonist, T0070907, that inhibits the adipogenic differentiation of TDSCs from injury-with-overuse tendinopathy.